cephalosporin c has been researched along with Neutropenia in 245 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (14.69) | 18.7374 |
| 1990's | 61 (24.90) | 18.2507 |
| 2000's | 102 (41.63) | 29.6817 |
| 2010's | 42 (17.14) | 24.3611 |
| 2020's | 4 (1.63) | 2.80 |
| Authors | Studies |
|---|---|
| Stamm, P; Urmann, E; Wisskirchen, J | 1 |
| Abdelraouf, K; Kidd, JM; Nicolau, DP | 1 |
| Ballanti, S; Busca, A; Candoni, A; Cattaneo, C; Cefalo, M; Criscuolo, M; Daffini, R; Dargenio, M; Del Principe, MI; Delia, M; Dragonetti, G; Fanci, R; Giuliano, G; Laurino, M; Maracci, L; Marchesi, F; Nadali, G; Pagano, L; Simonetti, E; Spolzino, A; Trecarichi, EM; Tumbarello, M; Zannier, ME | 1 |
| Abdulhamid, I; Ang, JY; Molloy, L; Srivastava, R | 1 |
| Fink, G; Horn, S; Kern, WV | 1 |
| Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK | 1 |
| Jansen, JW; Moenster, RP | 1 |
| Chan, D; Chang, E; Saedi-Kwon, H; Schwartz, J; Turner, RB; Wilson, DE; Won, R | 1 |
| Akova, M; Albasanz-Puig, A; Araos, R; Bote, A; Brunel, AS; Calik, S; Carratalà, J; Del Pozo, JL; Drgona, L; García, E; Gomes, MZR; Gudiol, C; Hemmati, P; Herrera, F; Ibrahim, KY; Isler, B; Kanj, S; Kern, W; Maestro de la Calle, G; Manzur, A; Marin, JI; Márquez-Gómez, I; Martín-Dávila, P; Mikulska, M; Montejo, JM; Montero, M; Morales, HMP; Morales, I; Novo, A; Oltolini, C; Parody, R; Peghin, M; Puerta-Alcalde, P; Ruiz-Camps, I; Sipahi, OR; Tebe, C; Tilley, R; Yáñez, L | 1 |
| Grau, S | 1 |
| Cook, PP; Frenkel, A; Rimawi, RH | 1 |
| Doron, SI; Epstein, L; Logvinenko, T; Muldoon, EG; Murray, S; Snydman, DR | 1 |
| Ding, H; Liang, C; Shan, Q; Wang, J; Zeng, Z | 1 |
| Barreto, JN; Tosh, PK; Wojenski, DJ; Wolf, RC | 1 |
| Li, J; Liang, C; Shan, Q; Wang, J; Zeng, Z | 1 |
| Crandon, JL; Nicolau, DP; So, W; Zhanel, GG | 1 |
| Kwan, BK; Yam, FK | 1 |
| Azzalis, LA; Bacci, MR; Bruniera, FR; Campos Junqueira, VB; da Luz Gonçalves Pedreira, M; Feder, D; Ferreira, FM; Fonseca, FL; Saviolli, LR; Sorgini Peterlini, MA | 1 |
| Anderson, SW; LaVie, KW; O'Neal, CS; O'Neal, HR; Rice, TW; Saavedra, TC | 1 |
| Guo, C; Liao, X; Liu, Y; Sun, J; Wang, F; Wang, M; Xiao, X; Yan, C | 1 |
| Ashbaugh, CD; Barra, M; Furtek, KJ; Koo, S; Kubiak, DW; Varughese, CA | 1 |
| Monogue, ML; Nicolau, DP | 1 |
| Ikawa, K; Ikeda, K; Morikawa, N; Nomura, K; Ohge, H; Sueda, T; Taniwaki, M | 1 |
| Heeney, MM; Hettmer, S | 1 |
| Iguchi, A; Kaneda, M; Kobayashi, K; Kobayashi, R; Sato, T; Yasuda, K | 1 |
| Andes, DR; Craig, WA | 1 |
| Cheong, HS; Chung, DR; Jung, CW; Kang, CI; Ko, KS; Peck, KR; Song, JH; Wi, YM | 1 |
| Choi, JH; Choi, SM; Lee, DG; Park, SH; Shin, WS; Yoo, JH | 1 |
| Hazar, V; Karasu, GT; Ogunc, D; Uygun, V; Yesilipek, A | 1 |
| Carlesse, FA; da Silva, KV; de Martino Lee, ML; Luisi, FA; Pereira, CA; Petrilli, AS | 1 |
| Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P | 1 |
| Garau, J; Gomez, L; Quintana, S | 1 |
| Berneman, ZN; Goossens, H; Mebis, J | 1 |
| Baldelli, F; Francisci, D; Malincarne, L; Martinelli, L; Masini, G | 1 |
| Choe, KW; Jang, HC; Jeon, JH; Kim, EC; Kim, HB; Kim, NJ; Lee, S; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
| Fujita, M; Inoshima, I; Inoue, Y; Kawasaki, M; Nakanishi, Y; Ohshima, T; Ouchi, H; Tokunaga, S; Wataya, H; Yoshimura, C | 1 |
| Bastús, R; Cirera, L; Estany, C; Estrada, C; Garau, J; Gómez, I; Gómez, L; Márquez, M; Martí, JM; Quintana, S | 1 |
| Chung, DR; Joung, MK; Kang, CI; Ko, KS; Lee, JA; Moon, SY; Peck, KR; Song, JH | 1 |
| Chong, Y; Ito, Y; Kamimura, T; Yakushiji, H | 1 |
| Cooper, C; Kim, PW; Kornegay, C; Nambiar, S; Rochester, G; Valappil, T; Wang, Y; Wu, YT | 1 |
| Bolay, S; Buclin, T; Calandra, T; Decosterd, LA; Lamoth, F; Marchetti, O; Pascual, A; Vora, S | 1 |
| Bellesso, M; Chamone, D; Costa, SF; Dorlhiac-Llacer, PE; Pracchia, LF; Santos Dias, LC | 1 |
| Bivas, A; Fraser, A; Leibovici, L; Paul, M; Yahav, D | 1 |
| Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Kaneda, M; Ohshima, J; Suzuki, D | 1 |
| Kalil, AC | 1 |
| Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M | 1 |
| Ambrose, PG; Bhavnani, SM; Blais, J; Hegde, SS; Obedencio, G; Okusanya, OO; Shaw, JP; Skinner, R | 1 |
| Beyene, J; Dupuis, LL; Lehrnbecher, T; Manji, A; Sung, L | 1 |
| Crandon, JL; Housman, ST; Keel, RA; Nicolau, DP; Williams, G | 1 |
| Ahmad, B; Ahmad, M; Aziz, MT; Hameed, H; Hussain, Y; Naseem, A | 1 |
| Komatsu, T; Takei, N | 1 |
| Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohta, K; Ohyashiki, K; Suzuki, K; Tamura, K; Urabe, A | 1 |
| Bhalodi, AA; Biek, D; Crandon, JL; Nicolau, DP | 1 |
| Chen, A; Chen, L; Du, L; Shi, L; Yu, Y; Yuan, T; Zheng, J | 1 |
| Andes, DR; Craig, WA; Lee, DG; Murakami, Y | 1 |
| Atsuta, Y; Emi, N; Inamoto, Y; Ishikawa, Y; Nagai, H; Naoe, T; Ozawa, Y; Ozeki, K; Suzuki, R; Terakura, S; Yanada, M; Yasuda, T | 1 |
| Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H | 1 |
| Jones, RN; Mutnick, AH; Turner, PJ | 1 |
| Alteraz, H; Blau, H; Fabian, I; Horev-Azaria, L; Kariv, N; Kletter, Y; Shalit, I; Shechtman, I | 1 |
| Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K | 1 |
| Gondoh, H; Hanada, S; Ikeda, S; Imamura, Y; Izumi, Y; Kawano, F; Masuda, M; Matsuishi, E; Matsuoka, H; Okamura, S; Saburi, Y; Shibuya, T; Tamura, K; Tsukada, J; Uike, N; Utsunomiya, A | 1 |
| Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A | 1 |
| Barr-Alí, M; Burgaleta, C; De Miguel, D; García-Suárez, J; Hernanz, N; Krsnik, I; Reyes, E | 1 |
| Gudiol, F; Marín, M | 1 |
| Baize, T; Fleming, DR; Goldsmith, GH; Herzig, RH; Mudd, L; Ziegler, C | 1 |
| Blot, N; Marie-Cardine, A; Schneider, P; Tron, P; Vannier, JP | 1 |
| Cornely, OA; Karthaus, M | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Ko, GJ; Wong, BB | 1 |
| Abdulkadyrov, KM; Chebotkevich, VN; Chudanova, TV | 1 |
| Kliasova, GA | 1 |
| Blijlevens, N; de Pauw, B; Donnelly, P; Levenga, H; Shirango, H; Verweij, P | 1 |
| Fujii, N; Fukuda, S; Hara, M; Harada, M; Ikeda, K; Imajoh, K; Ishimaru, F; Kojima, K; Miyata, A; Nakase, K; Nawa, Y; Saito, T; Shinagawa, K; Sunami, K; Takeuchi, M; Tanimoto, M; Teshima, T; Yano, T | 1 |
| Akyüz, C; Büyükpamukçu, M; Ceyhan, M; Kanra, G; Kurne, O; Kutluk, T; Seçmeer, G | 1 |
| Babalola, CP; Nicolau, DP; Nightingale, CH | 1 |
| Akiyama, N; Imajo, K; Masaoka, T; Ohyashiki, K; Suzuki, K; Tamura, K; Tanimoto, M; Urabe, A | 1 |
| Ohyashiki, K | 1 |
| Fong, LD; Forrest, A; Paladino, JA; Ramphal, R | 1 |
| Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P | 1 |
| Wong-Beringer, A | 1 |
| Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A | 1 |
| Demiroz, AP; Ertem, G; Hatipoglu, CA; Irmak, H; Kinikli, S; Kocak, Z; Tufan, A | 1 |
| Huijgens, PC; Simoons-Smit, AM; Swart, EL; Timmers, GJ; van Vuurden, DG | 1 |
| Fraser, A; Leibovici, L; Paul, M; Yahav, D | 1 |
| Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G | 1 |
| Hnátková, M; Jedlicková, A; Klener, P; Trnený, M; Vacková, B; Zikesoá, E | 1 |
| Colson, YL; Marty, FM; Paul, S | 1 |
| Bow, EJ; Laverdiere, M; Noskin, GA; Rotstein, C; Sanche, S; Schwarer, AP; Segal, BH; Seymour, JF; Szer, J | 1 |
| Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K | 1 |
| Abdullah, WA; Ai, CL; Ariffin, H; Lee, CL | 1 |
| Patel, SM; Saravolatz, LD | 1 |
| Amador, ML; Arcediano, A; Bazares, S; Castellano, D; Ciruelos, E; Cortés-Funes, H; González-Cortijo, L; Hornedo, J; Jimeno, A; Lumbreras, C; Paz-Ares, L; Robles, L | 1 |
| Ellis-Pegler, R; Palmer, S; Ritchie, S | 1 |
| Dan, K; Yokose, N | 1 |
| Chang, MC; Chang, YF; Huang, CY; Peng, MY; Sheu, YT; Su, YC; Tsao, SM; Wang, SM; Wu, MF; Yeh, KM | 1 |
| Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA | 1 |
| Grigg, AP; Roberts, AW; Sainani, A; Schwarer, AP; Slavin, MA; Spencer, A; Szer, J; Thursky, KA | 1 |
| Hamidah, A; Jamal, R; Lim, YS; Nordiah, AJ; Zarina, AL; Zulkifli, SZ | 1 |
| Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeoung, SJ; Kim, CK; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Lee, HS; Lee, K; Song, YG; Yong, D; Yum, JH | 1 |
| Ikawa, K; Ikeda, K; Kuribayashi, M; Morikawa, N; Nomura, K; Taniwaki, M | 1 |
| Corcoran, E; Dudley, MN; Griffith, DC; Rodriguez, D | 1 |
| Chung, HJ; Kim, MN; Ko, SY; Sung, HS | 1 |
| Cheong, HS; Heo, ST; Jung, CW; Ki, HK; Kim, KH; Kwon, KT; Moon, CS; Peck, KR; Rhee, JY; Ryu, SY; Song, JH; Wi, YM | 1 |
| Fujimoto, Y; Fujita, N; Ikawa, K; Ikeda, K; Kanbayashi, Y; Komori, T; Matsumoto, Y; Morikawa, N; Nomura, K; Shimazaki, C; Shimizu, D; Shimura, K; Taniguchi, K; Taniwaki, M | 1 |
| Brown, M; Chee, L; Grigg, AP; MacGregor, L; Sasadeusz, J | 1 |
| Chaigneau, H; Eveno, J; Mariel, C; Tancrede, C | 1 |
| Galea, G | 1 |
| Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB; Valdivieso, M | 1 |
| Duerden, BI; Lilleyman, JS; Morgan, G | 1 |
| Darbyshire, PJ; Mott, MG; Oakhill, A; Pedler, SJ; Speller, DC; Williamson, PJ | 1 |
| Foord, RD | 1 |
| Bellingham, AJ; Bennet, C; Brada, M; Hart, CA; Reilly, JT | 1 |
| Lassoued, K; Regnier, B; Rouveix, B; Vittecoq, D | 1 |
| Drake, TA; Hackbarth, CJ; Rusnak, MG; Sande, MA | 1 |
| Arrenbrecht, S; Erni, J; Hauser, S; Müller, M; Neftel, K; Wälti, M | 1 |
| Klastersky, J | 3 |
| Bodey, GP; Valdivieso, M; Yap, BS | 1 |
| Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F | 1 |
| de Meyer, A; Lauwers, S; Piérard, D | 1 |
| Baki, M; Bodrogi, I; Géczi, L; Horti, J | 1 |
| Branger, JM; Geers, AB; Hart, HC; Hoepelman, AI; Kieft, H; Kluyver, M; Poest-Clement, E; Rozenberg-Arska, M; van Beugen, L; Voskuil, JH | 1 |
| Garratty, G | 1 |
| Ang, PT; Au, E | 1 |
| Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M | 1 |
| Ishibashi, K; Ogihara, M; Shigeta, S; Shiraiwa, Y; Yamaguchi, O | 1 |
| Aquino, VM; Buchanan, GR; Mustafa, MM; Pappo, A; Tkaczewski, I | 1 |
| Cimino, M; Gucalp, R; Oblon, D; Ramphal, R; Rotstein, C | 1 |
| Dankert, J; Kamps, WA; Muis, N | 1 |
| Fernández González, F; Fernández Rodríguez, E; Moreno García, M; Portús de Marco, MV | 1 |
| Dopff, C; Gérard, A; Le Meins, V; Maurer, P; Witz, B | 1 |
| Geletko, SM; Melbourne, KM; Mikolich, DJ | 1 |
| Bjökholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G | 1 |
| Anaissie, EJ; Barbounakis, E; Bodey, GP; Karyotakis, NC; Maraki, S; Samonis, G; Tselentis, Y | 1 |
| Aparicio, J; Gómez-Codina, J; Herranz, C; Llorca, C; Montalar, J; Munárriz, B; Oltra, A; Pastor, M | 1 |
| Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C | 1 |
| Cartwright, K; Dooley, J; Fairclough, P; Mani, V; Oakley, C; Swarbrick, E | 1 |
| Charnas, R; Lüthi, AR; Ruch, W | 1 |
| Rossi, JF | 1 |
| Hathorn, JW; Lyke, K | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Lamb, HM; Wiseman, LR | 1 |
| Carlisle, P; Cimino, M; Gucalp, R; Roberts, J; Rotstein, C; Yamamura, D | 1 |
| Dahlgren, AF | 1 |
| Battles, A; Liu, QF; Liu, W; Louie, A; Miller, DA; Miller, MH; Sucke, AC | 1 |
| Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M | 1 |
| Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B | 1 |
| Böhme, A; Hoelzer, D; Shah, PM; Stille, W | 1 |
| Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A | 1 |
| Egerer, G; Jürgens, H; Karthaus, M; Kullmann, KH; Ritter, J | 1 |
| Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J | 1 |
| Adriansson, M; Andreasson, B; Bäckström, B; Johansson, P; Karlsson, K; Lindblad, R; Rhedin, C; Rödjer, S; Turesson, I | 1 |
| Barberán, J; Ferrádez, A; Gomis, M; Sánchez, B | 1 |
| Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M | 1 |
| Madiajagane, R | 1 |
| Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM | 1 |
| Gyarfás, J; Krcmery, V; Kunová, A; Mateicka, F; Spánik, S; Sycová, Z; Trupl, J | 1 |
| Abe, T; Fukuda, M; Hirashima, K; Karasawa, M; Miura, Y; Moriyama, Y; Motoyoshi, K; Nagata, N; Naruse, T; Ninomiya, H; Oh, H; Saito, K; Shibata, A; Shishido, H; Yoshida, M | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
| Barbabietola, G; Bucaneve, G; Cavicchi, F; Del Favero, A; Gentile, G; Iori, AP; Landonio, G; Martino, P; Menichetti, F; Micozzi, A; Minotti, V | 1 |
| Chan, KW; Culbert, SJ; Danielson, M; Jeha, SS; Kuttesch, JF; Mullen, CA; Petropoulos, D; Roberts, WM; Rolston, KV; Rytting, M; Zipf, T | 1 |
| Björkholm, M; Dornbusch, K; Engervall, P; Kalin, M | 1 |
| Egerer, G; Ehrhard, I; Goldschmidt, H; Haas, R; Sonntag, HG; Streich, N | 1 |
| Iakovlev, SV | 1 |
| Fauser, AA; Finke, J; Höffken, G; Pasold, R; Pflüger, KH; Szelenyi, H; Wagner, J | 1 |
| Claeys, G; De Baere, T; Peleman, R; Steyaert, S; Vaneechoutte, M; Verschraegen, G | 1 |
| Antabli, BA; Bross, P; Siegel, RS; Small, CD; Tabbara, IA | 1 |
| Dmitrieva, NV; Minenko, SV; Ptushkin, VV; Sokolova, EN | 1 |
| Campos, MC; Dantas, LS; Ginani, VC; Petrilli, AS; Seber, A; Tanaka, C | 1 |
| Abdullah, WA; Arasu, A; Ariffin, H; Lee, CL; Mohamed, M; Navaratnam, P; Peng, LH | 1 |
| Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D | 1 |
| Clark, PI; Kelly, V; Marshall, E; Murray, A; O'Reilly, SM; Smith, DB | 1 |
| Ferrant, A; Gérain, J; Humblet, Y; Longueville, J; Moreau, M; Straetmans, N; Symann, M; Vandercam, B; Wauters, G | 1 |
| Egerer, G; Ehrhard, I; Goldschmidt, H; Haas, R; Hegenbart, U; Ho, AD; Salwender, H | 1 |
| Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA | 1 |
| Egerer, G; Fenchel, K; Franke, A; Heil, G; Jürgens, H; Kämpfe, D; Karthaus, M; Peters, G; Ritter, J; Südhoff, T | 1 |
| Bethe, U; Cornely, OA; Diehl, V; Fätkenheuer, G; Salzberger, B; Schrappe, M; Seifert, H | 1 |
| Egerer, G; Jürgens, H; Karthaus, M | 1 |
| Fabbri, A; Fanci, R; Leoni, F; Longo, G; Martinez, RL; Paci, C; Pecile, P | 1 |
| Bucaneve, G; Del Favero, A; Dionisi, MS; Furno, P; Menichetti, F | 1 |
| Arnow, PM; Chandrasekar, PH | 1 |
| Bradley, SJ | 1 |
| Berman, S; DePauw, B; Feld, R; Ho, W; Keating, A | 1 |
| Kim, MY; Lee, CS; Paek, KS; Youn, H | 1 |
| Baker, DK; Flynn, PM; Hetherington, SV; Hudson, MM; Hughes, WT; Patrick, CC; Roberson, PK; Sandlund, JT; Santana, VM; Shenep, JL; Sixbey, JW; Slobod, KS | 1 |
| Boylan, CJ; Contag, PR; Foley, JW; Iversen, PW; Jenkins, DE; LeTourneau, DL; McMillian, CL; Parr, TR; Rocchetta, HL | 1 |
| Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Marron, A | 1 |
| Heiss, M; Kern, WV; Steinbach, G | 1 |
| Bhattacharjee, AK; Cross, AS; Glaser, K; Opal, SM; Palardy, JE; Parejo, NA; Warren, HS | 1 |
| Akici, F; Ayan, I; Görgün, O; Gürler, N; Kebudi, R; Töreci, K | 1 |
| Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P | 1 |
| Ljungberg, B; Nilsson-Ehle, I; Nyhlén, A | 1 |
| Buchanan, GR; Carlson, L; McCracken, GH; Mustafa, MM; Tkaczewski, I | 1 |
| Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J | 1 |
| Crawford, S; Jorgensen, JH; McElmeel, ML; Murray, CK; Walter, EA | 1 |
| Kuliczkowski, K; Mazur, G; Wróbel, T | 1 |
| Bode, U; Fleischhack, G; Hartmann, C; Hasan, C; Havers, W; Marklein, G; Simon, A; Wulff, B | 1 |
| Agaoglu, L; Agirbasli, H; Anak, S; Bilgen, H; Biner, B; Can, M; Devecioglu, O; Eryilmaz, E; Gedikoglu, G; Goksan, B; Karakas, Z; Unuvar, A; Yalman, N | 1 |
| Morrison, DC; Opal, SM; Palardy, JE; Parejo, N | 1 |
| Friedrich, LV; Kays, MB; White, RL | 1 |
| Bauduer, F; Boiron, JM; Boulat, O; Cousin, T; Fegueux, N; Jourdan, E; Molina, L; Reiffers, J; Rigal-Huguet, F | 1 |
| Akan, H; Akova, M; Cetinkaya, Y; Erman, M; Ferhanoğlu, B; Köksal, I; Korten, V; Unal, S; Uzun, O | 1 |
| Landau, M; Nucci, M; Pulcheri, W; Silveira, F; Spector, N | 1 |
| Bethe, U; Breuer, K; Cornely, OA; Fätkenheuer, G; Salzberger, B; Schrappe, M; Schütt-Gerowitt, H; Seifert, H | 1 |
| Oh, HM; Tan, AL | 1 |
| Ptushkin, VV | 1 |
| Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
| Paganini, H; Zubizarreta, P | 1 |
| Malik, I | 1 |
| Chuang, YY; Huang, YC; Hung, IJ; Jaing, TH; Lin, TY; Yang, CP | 1 |
| Batlle, M; Benlloch, L; Capote, FJ; Gutiérrez, M; Jarque, I; Julià, A; Lahuerta, JJ; Larrea, L; López, J; Palau, J; Pérez, C; Ramos, F; Rovira, M; Sanz, MA; Vázquez, L | 1 |
| Fabre, S; Jennis, F; Vincent, PC | 1 |
| Kunst, MW; Mattie, H; van Furth, R | 1 |
| Sato, K; Yoshino, T | 1 |
| Hasuike, T; Hirai, M; Inoue, T; Misu, K; Nakao, Y; Ohira, H; Ota, K; Tanaka, K; Yamane, T; Yasui, Y | 1 |
| Blake, J; Cassiano-Clough, L; Cosand, WL; Cunningham, MD; Darveau, RP; Maloney, G; Seachord, CL | 1 |
| Aguado, JM; Alsar, MJ; Baro, J; Conde, E; Garijo, J; Gómez Casares, MT; Iriondo, A; Muruzábal, MJ; Pérez, M; Richard, C | 1 |
| Butler, K; Gress, J; Lecciones, J; Lee, J; Marshall, D; Pizzo, PA; Roilides, E; Rubin, M; Walsh, T; Weinberger, M | 1 |
| Pizzo, PA; Rubin, M | 1 |
| Pizzo, PA | 1 |
| Becker, EW; Berg, PA; Himmelsbach, M; Palitzsch, D | 1 |
| González Quintela, A; Martin Martin, F; Millán, I; Moya Mir, M; Román García, J; Vidal Pan, C | 1 |
| Abruzzo, GK; Bland, JA; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Hadley, SK; Pelak, BA; Weissberger, BA | 1 |
| Chapman, JF; Metcalfe, P; Murphy, MF; Waters, AH | 1 |
| Bloom, JC; Deldar, A; Lewis, HB; Sellers, TS; Thiem, PA | 1 |
| Hathorn, JW; Pizzo, PA | 1 |
| Bloom, JC; Deldar, A; Lewis, HB; Sellers, TS | 1 |
| Fu, KP; Gregory, FJ; Hetzel, N; Hung, PP | 2 |
| Cooke, RP; Ganguli, LA; Schofield, KP | 1 |
| Barriere, SL | 1 |
| Amess, JA; Green, AR; Grint, PC; Knowles, S; Metcalfe, P; Murphy, MF; Waters, AH | 1 |
| Bezwoda, WR; Cassel, R; Derman, DP; Perkins, S | 1 |
| Hauser, SP; Müller, MR; Neftel, KA; Wälti, M | 1 |
| Ghosh, S; Lawson, AA; McArdle, T | 1 |
| Hauser, SP; Müller, MR; Neftel, KA | 1 |
| Ellis, CJ; Geddes, AM | 1 |
| Young, LS | 1 |
| Hansen, LA; McDaniel, PA; Parr, MD; Waite, WW | 1 |
| Bran, JL; Jepson, JH; Kaye, D; Levison, ME | 1 |
27 review(s) available for cephalosporin c and Neutropenia
| Article | Year |
|---|---|
Safety and tolerability of ceftobiprole.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Neutropenia; Pneumonia, Bacterial; Pseudomonas aeruginosa; Streptococcus pneumoniae | 2019 |
The use of vancomycin with its therapeutic and adverse effects: a review.
Topics: Anti-Bacterial Agents; Cephalosporins; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neutropenia; Vancomycin | 2015 |
Meta-analysis of a possible signal of increased mortality associated with cefepime use.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Fever of Unknown Origin; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neutropenia; Pneumonia, Bacterial; Skin Diseases, Bacterial; Survival Analysis; Urinary Tract Infections; Young Adult | 2010 |
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fever; Humans; Imipenem; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Thienamycins | 2010 |
A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Fever of Unknown Origin; Hospitals, Pediatric; Humans; Neutropenia; Penicillins; Treatment Outcome | 2012 |
Ceftriaxone in febrile neutropenia.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Male; Neutropenia; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome | 2003 |
[Empirical cefepime monotherapy in febrile neutropenia].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Clinical Trials as Topic; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Neutropenia; Pseudomonas aeruginosa; Sensitivity and Specificity | 2003 |
Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius--a pathogen or passenger?
Topics: Actinomycetales; Actinomycetales Infections; Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Translocation; Cefepime; Cephalosporins; Clostridium Infections; Colistin; Cytarabine; Daunorubicin; Drug Therapy, Combination; Etoposide; Fatal Outcome; Hemoptysis; Humans; Hydroxyurea; Immunocompromised Host; Intestinal Mucosa; Leukemia, Myeloid, Acute; Male; Metronidazole; Middle Aged; Neutropenia; Pneumonia, Bacterial; Superinfection; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Treating serious infections: focus on cefepime.
Topics: Cefepime; Cephalosporins; Cross Infection; Humans; Neutropenia; Pneumonia, Bacterial | 2004 |
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enzyme Inhibitors; Fever; Humans; Neutropenia; Penicillanic Acid; Penicillins; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome | 2006 |
Monotherapy versus combination therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cellulitis; Cephalosporins; Ciprofloxacin; Diverticulitis; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Meningitis, Bacterial; Neutropenia; Osteomyelitis; Pneumonia; Staphylococcus aureus; Viridans Streptococci | 2006 |
Pasteurella multocida sepsis, due to a scratch from a pet cat, in a post-chemotherapy neutropenic patient with non-Hodgkin lymphoma.
Topics: Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Anticoagulants; Bites and Stings; Cats; Cefepime; Cephalosporins; Chondroitin Sulfates; Dermatan Sulfate; Female; Granulocyte Colony-Stimulating Factor; Heparitin Sulfate; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Pasteurella Infections; Pasteurella multocida; Sepsis | 2007 |
[Review of drugs used in the neutropenic period following cytostatic therapy and comparative study of doxycycline and ofloxacin in the treatment of patients with testicular cancer].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Dose-Response Relationship, Drug; Doxycycline; Humans; Hungary; Male; Neutropenia; Ofloxacin; Testicular Neoplasms | 1994 |
Immune cytopenia associated with antibiotics.
Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Autoimmune Diseases; Blood Cells; Cephalosporins; Hematologic Diseases; Humans; Neutropenia; Penicillins; Thrombocytopenia | 1993 |
Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Imipenem; Meropenem; Neutropenia; Thienamycins | 1997 |
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.
Topics: Animals; Bacterial Infections; Cefpirome; Cephalosporins; Fever; Humans; Neutropenia | 1997 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
[Cefepim in febrile neutropenic patients].
Topics: Adult; Cefepime; Cephalosporins; Child; Fever; Gentamicins; Humans; Neutropenia; Penicillins; Piperacillin | 1998 |
[Cefepime--a fourth generation cephalosporin antibiotic].
Topics: Bacterial Infections; Cefepime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neutropenia; Peritonitis | 1999 |
Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Middle Aged; Mortality; Neutropenia; Odds Ratio; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome | 2000 |
Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Fever; Humans; Infant; Neoplasms; Neutropenia; Safety; Treatment Outcome | 2001 |
[Cephalosporins in empirical treatment of neutropenic fever].
Topics: Antineoplastic Agents; Cephalosporins; Drug Resistance, Microbial; Fever; Humans; Neoplasms; Neutropenia | 2001 |
Shigella septicaemia in adults: report of two cases and mini-review.
Topics: Ceftriaxone; Cephalosporins; Diarrhea; Female; Humans; Middle Aged; Neutropenia; Renal Insufficiency; Risk Factors; Sepsis; Shigella flexneri; Thrombocytopenia | 2001 |
[Use of maxipime in treating infections in neutropenic patients].
Topics: Bacterial Infections; Cefepime; Cephalosporins; Humans; Neutropenia | 2001 |
The febrile neutropenic patient: newer options for empirical therapy.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Neutropenia; Quinolones | 1990 |
Combating infections in neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mycoses; Neoplasms; Neutropenia | 1989 |
Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Neoplasms; Neutropenia | 1986 |
83 trial(s) available for cephalosporin c and Neutropenia
| Article | Year |
|---|---|
A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefozopran; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Prospective Studies; Survival Rate | 2008 |
Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2009 |
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Male; Neutropenia; Treatment Outcome; Young Adult | 2009 |
Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Agents; Blood; Cefepime; Cephalosporins; Female; Fever; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sputum | 2010 |
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poisoning; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2011 |
A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Drug Therapy, Combination; Female; Fever; Humans; Infant; Infant, Newborn; Lymphoma; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Treatment Outcome; Young Adult | 2011 |
Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Female; Fever; Hematologic Diseases; Humans; Male; Meropenem; Neutropenia; Prospective Studies; Thienamycins; Treatment Outcome; Young Adult | 2013 |
Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Treatment Outcome; Young Adult | 2013 |
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins | 2013 |
Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
Topics: Adult; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Neutropenia | 2002 |
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Aztreonam; Cefepime; Cephalosporins; Clavulanic Acid; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Humans; Immunocompromised Host; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Ticarcillin | 2003 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
[Cefepime/amikacin in the empirical antibacterial therapy for patients with hemoblastosis of different forms].
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Leukocyte Count; Neutropenia; Neutrophils; Time Factors; Treatment Outcome | 2003 |
[Clinical evaluation of cefozopran as treatment for febrile neutropenia].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia | 2004 |
Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Empiricism; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Meropenem; Neoplasms; Neutropenia; Therapeutic Equivalency; Thienamycins; Treatment Outcome | 2004 |
Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
Topics: Amikacin; Antineoplastic Agents; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Japan; Leukemia; Male; Neutropenia; Opportunistic Infections | 2004 |
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome | 2004 |
Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies.
Topics: Aged; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia | 2005 |
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2006 |
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Treatment Failure; Treatment Outcome | 2006 |
Cefepime monotherapy for treatment of febrile neutropenia in children.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Malaysia; Male; Neoplasms; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 2006 |
Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Stem Cell Transplantation; Treatment Outcome | 2006 |
An observational study on the empiric use of cefpirome in febrile neutropenia.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Endpoint Determination; Fever; Humans; Injections, Intravenous; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Taiwan; Time Factors; Treatment Outcome | 2007 |
A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Time Factors; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2007 |
Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Remission Induction | 2007 |
Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Survival Rate; Thienamycins; Treatment Outcome | 2008 |
Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Female; Fever; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Neutropenia; Plasma | 2008 |
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Ceftazidime as a single agent in the management of children with fever and neutropenia.
Topics: Adolescent; Agranulocytosis; Anemia, Aplastic; Azlocillin; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neoplasms; Neutropenia; Penicillins; Random Allocation; Tobramycin | 1983 |
Ceftazidime: aspects of efficacy and tolerance.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Coombs Test; Enterobacteriaceae Infections; Eosinophilia; Humans; Liver Function Tests; Neutropenia; Pseudomonas Infections; Staphylococcal Infections | 1983 |
[Review of drugs used in the neutropenic period following cytostatic therapy and comparative study of doxycycline and ofloxacin in the treatment of patients with testicular cancer].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Dose-Response Relationship, Drug; Doxycycline; Humans; Hungary; Male; Neutropenia; Ofloxacin; Testicular Neoplasms | 1994 |
Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Humans; Neutropenia; Treatment Failure; Treatment Outcome | 1994 |
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins | 1995 |
Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Fever; Humans; Leukemia; Leukocyte Count; Male; Meropenem; Middle Aged; Neutropenia; Prospective Studies; Thienamycins; Treatment Failure | 1995 |
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillins; Piperacillin; Prospective Studies; Superinfection; Vancomycin | 1996 |
Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Blood; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Neutropenia; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Prospective Studies; Thienamycins | 1996 |
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 1997 |
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Chil
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia | 1997 |
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Cilastatin; Drug Synergism; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Netilmicin; Neutropenia; Postoperative Complications; Protease Inhibitors; Thienamycins; Treatment Outcome | 1997 |
Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.
Topics: Adult; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin | 1997 |
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins | 1998 |
Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.
Topics: Anti-Infective Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Neutropenia; Penicillanic Acid; Pilot Projects; Piperacillin; Prognosis; Prospective Studies; Tazobactam | 1998 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1998 |
Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antibiotic Prophylaxis; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Infant; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 1998 |
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin | 1998 |
Empiric monotherapy for febrile neutropenia--a randomized study comparing meropenem with ceftazidime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cephalosporins; Female; Fever; Humans; Male; Meropenem; Middle Aged; Neutropenia; Opportunistic Infections; Thienamycins; Treatment Outcome | 1998 |
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis | 1998 |
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Treatment Outcome | 1999 |
Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Lenograstim; Leukocyte Count; Male; Middle Aged; Neutropenia; Pneumonia; Recombinant Proteins; Tobramycin; Treatment Outcome | 1999 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Fever; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Neutropenia; Outpatients; Prospective Studies; Treatment Outcome | 1999 |
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Topics: Adolescent; Ambulatory Care; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Prospective Studies; Risk Assessment | 1999 |
Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefepime; Cephalosporins; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia | 1999 |
An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Neutropenia; Superinfection; Treatment Outcome | 1999 |
Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia | 1999 |
[Cefepime in the treatment of infection in neutropenic patients].
Topics: Adolescent; Adult; Bacterial Infections; Cefepime; Cephalosporins; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Time Factors; Treatment Outcome | 1999 |
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Anti-Infective Agents; Antineoplastic Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Fever; Humans; Neoplasms; Neutropenia; Prospective Studies; Risk Factors | 2000 |
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Tolerance; Female; Fever; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Thienamycins | 2000 |
Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation.
Topics: Adolescent; Adult; Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; Catheterization, Central Venous; Ceftazidime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neutropenia; Prospective Studies | 2000 |
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors | 2000 |
Interventional once-daily administration of ceftriaxone in leukemia and lymphoma patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Treatment Outcome | 2000 |
Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
Topics: Adult; Aged; Antineoplastic Agents; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Fever; Hematologic Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Treatment Outcome | 2000 |
Outpatient treatment of cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Fever; Humans; Infant; Infusions, Intravenous; Middle Aged; Neoplasms; Neutropenia; Outpatients; Prospective Studies; Treatment Outcome | 2000 |
Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2000 |
Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Double-Blind Method; Female; Fever; Humans; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Treatment Failure; Treatment Outcome | 2000 |
Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cephalosporins; Double-Blind Method; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Thienamycins | 2000 |
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Consumer Product Safety; Female; Fever; Humans; Infant; Injections, Intravenous; Male; Neoplasms; Neutropenia; Treatment Failure | 2001 |
Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
Topics: Adolescent; Antineoplastic Agents; Bacterial Infections; Candidiasis; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Statistics, Nonparametric | 2001 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2001 |
Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Fever; Humans; Infant; Neoplasms; Neutropenia; Safety; Treatment Outcome | 2001 |
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Escherichia coli; Female; Fever; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Relapsing Fever; Thienamycins; Time Factors; Treatment Outcome | 2001 |
Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Topics: Adolescent; Adult; Amikacin; Cefepime; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Meropenem; Neoplasms; Netilmicin; Neutropenia; Prospective Studies; Thienamycins; Turkey | 2001 |
A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Cefpirome; Cephalosporins; Enzyme Inhibitors; Female; Fever; France; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 2001 |
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Leukemia; Lymphoma, Non-Hodgkin; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome | 2001 |
A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.
Topics: Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Fever; Gentamicins; Humans; Neutropenia; Prospective Studies; Treatment Outcome | 2002 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
Topics: Adolescent; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Treatment Outcome | 2002 |
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 2002 |
Combating infections in neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mycoses; Neoplasms; Neutropenia | 1989 |
Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Random Allocation; Tobramycin | 1985 |
138 other study(ies) available for cephalosporin c and Neutropenia
| Article | Year |
|---|---|
[Cefiderocol in AML patient with neutropenic infection due to 4MRGN Klebsiella pneumoniae (VIM-1)].
Topics: Aged; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Communicable Diseases; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neoplasm Recurrence, Local; Neutropenia | 2023 |
Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cefepime; Cephalosporins; Cyclooctanes; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Lung; Mice; Microbial Sensitivity Tests; Neutropenia; Piperidines; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms | 2020 |
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infection Control; Italy; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prospective Studies; Risk Factors | 2019 |
Ceftolozane/Tazobactam Treatment of Multidrug-resistant Pseudomonas aeruginosa Infections in Children.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome; Young Adult | 2020 |
[Antibiotic stewardship - recent developments].
Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Cephalosporins; Fluoroquinolones; Germany; Humans; Neutropenia; Piperacillin, Tazobactam Drug Combination; Urinary Tract Infections | 2020 |
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2017 |
Rate and Incidence of Adverse Reactions Associated With Ceftaroline Exposure: Importance of Cutaneous Manifestations.
Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Exanthema; Female; Humans; Hypersensitivity; Incidence; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Staphylococcal Infections | 2018 |
Comparative analysis of neutropenia in patients receiving prolonged treatment with ceftaroline.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Female; Humans; Incidence; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2018 |
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; International Cooperation; Logistic Models; Multicenter Studies as Topic; Neoplasms; Neutropenia; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Retrospective Studies; Tazobactam; Time Factors | 2019 |
Ceftaroline - a cause for neutropenia.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Humans; Neutropenia; Pneumonia, Bacterial | 2013 |
The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Clostridioides difficile; Clostridium Infections; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Neutropenia; Retrospective Studies | 2013 |
Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Disease Models, Animal; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Tandem Mass Spectrometry; Thigh | 2014 |
Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefpodoxime; Ceftizoxime; Cephalosporins; Female; Fever; Fluoroquinolones; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Young Adult | 2014 |
In vivo activity of cefquinome against Escherichia coli in the thighs of neutropenic mice.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, Liquid; Escherichia coli; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Tandem Mass Spectrometry; Thigh | 2014 |
Comparison of in vivo and in vitro pharmacodynamics of a humanized regimen of 600 milligrams of Ceftaroline Fosamil every 12 hours against Staphylococcus aureus at initial inocula of 106 and 108 CFU per milliliter.
Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus | 2014 |
A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline.
Topics: Aged; Agranulocytosis; Anti-Bacterial Agents; Arthritis, Infectious; Ceftaroline; Cephalosporins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Neutropenia; Off-Label Use | 2014 |
Neutropenia Associated with Long-Term Ceftaroline Use.
Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Humans; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Neutrophils; Retrospective Studies; Staphylococcal Infections; Time Factors | 2016 |
In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Streptococcal Infections; Streptococcus suis; Thigh | 2016 |
High incidence of neutropenia in patients with prolonged ceftaroline exposure.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Boston; Ceftaroline; Cephalosporins; Female; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Young Adult | 2016 |
In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Colistin; Culture Media; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tobramycin; Treatment Outcome | 2016 |
Pharmacokinetic-pharmacodynamic target attainment analysis of cefozopran in Japanese adult patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Female; Humans; Laparotomy; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Neutropenia | 2008 |
Cefepime-induced neutropenia in a teenager.
Topics: Accidents, Traffic; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Neutropenia; Serratia Infections; Serratia marcescens; Spinal Fractures; Spinal Fusion; Surgical Wound Infection; Vancomycin | 2008 |
In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporin Resistance; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Enterobacteriaceae Infections; Extremities; Female; Gram-Negative Bacterial Infections; Lung Diseases; Methicillin Resistance; Mice; Mice, Inbred ICR; Neutropenia; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Neutropenia; Treatment Failure; Young Adult | 2009 |
Current antimicrobial usage for the management of neutropenic fever in Korea: a nationwide survey.
Topics: Administration, Oral; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Data Collection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Korea; Neoplasms; Neutropenia; Prospective Studies; Surveys and Questionnaires; Time Factors; Treatment Failure | 2008 |
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors | 2009 |
Mortality associated with cefepime therapy among neutropenic patients.
Topics: Anti-Bacterial Agents; Cause of Death; Cefepime; Cephalosporins; Humans; Neutropenia; Randomized Controlled Trials as Topic; Risk Factors | 2009 |
Cefepime and mortality.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Neutropenia | 2009 |
A case of severe cefepime-related neutropenia in a 15-year-old patient.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Humans; Male; Neutropenia; Osteoarthritis; Surgical Wound Infection | 2010 |
Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Risk Factors; Severity of Illness Index; Treatment Outcome | 2010 |
Efficacy of cefepime therapy for Enterobacter bacteraemia, with special emphasis on febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Treatment Outcome | 2010 |
Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Fever; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.
Topics: Adult; Aged; Cefepime; Cephalosporins; Female; Glomerular Filtration Rate; Hallucinations; Humans; Male; Middle Aged; Nervous System; Neutropenia; Retrospective Studies | 2010 |
Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Fever; Hematologic Neoplasms; Home Infusion Therapy; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Retrospective Studies; Teicoplanin; Treatment Outcome | 2011 |
Is cefepime safe for clinical use? A Bayesian viewpoint.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Fever of Unknown Origin; Humans; Incidence; Neutropenia; Skin Diseases, Bacterial; Statistics as Topic; United States | 2011 |
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome | 2010 |
Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Colony Count, Microbial; Dimerization; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycopeptides; Humans; Injections, Subcutaneous; Mice; Microbial Sensitivity Tests; Neutropenia; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Thigh; Vancomycin | 2012 |
Efficacy of human simulated exposures of ceftaroline against phenotypically diverse Enterobacteriaceae isolates.
Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Immunocompetence; Injections, Intravenous; Klebsiella; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Phenotype; Thigh | 2012 |
[Current clinical practice in the treatment of febrile neutropenia (FN)].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Pathways; Evidence-Based Medicine; Fever; Humans; Japan; Meropenem; Neutropenia; Physicians; Practice Guidelines as Topic; Practice Patterns, Physicians'; Surveys and Questionnaires; Thienamycins | 2011 |
Efficacy of ceftaroline fosamil in a staphylococcal murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Pneumonia, Staphylococcal; Protein Binding | 2012 |
Risk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patients.
Topics: Abdomen; Candidemia; Case-Control Studies; Catheterization, Central Venous; Cephalosporins; Cross Infection; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care, Neonatal; Intubation, Intratracheal; Logistic Models; Meningitis, Fungal; Multivariate Analysis; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Urinary Tract Infections | 2013 |
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin | 2013 |
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins | 2002 |
Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Body Weight; Bronchopneumonia; Candidiasis; Ceftazidime; Cephalosporins; Cyclophosphamide; Cytokines; Fluoroquinolones; Lung; Male; Mice; Mice, Inbred BALB C; Moxifloxacin; Neutropenia; Protein Synthesis Inhibitors; Quinolines; Survival | 2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Data Collection; Drug Therapy, Combination; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Vancomycin | 2002 |
Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftazidime; Cephalosporins; Chi-Square Distribution; Hematologic Neoplasms; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome | 2003 |
[beta-Lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Endocarditis, Bacterial; Humans; Molecular Structure; Monobactams; Neutropenia; Penicillins; Respiratory Tract Infections; Soft Tissue Infections; Staphylococcal Skin Infections; Urinary Tract Infections | 2003 |
[Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Infant; Neoplasms; Neutropenia; Patient Selection; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
Neutropenia in patients receiving long-term cefepime therapy for osteomyelitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neutropenia; Osteomyelitis | 2003 |
Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
Topics: Alkylating Agents; Animals; Ceftazidime; Cephalosporins; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Female; Granulocyte Colony-Stimulating Factor; Mice; Neutropenia; Pneumonia, Bacterial; Pseudomonas Infections; Survival Analysis | 2004 |
Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections; Risk Assessment; Sepsis | 2004 |
Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy. For the treatment of febrile episodes in neutropenic patients.
Topics: Aminoglycosides; Cephalosporins; Cost-Benefit Analysis; Drug Therapy, Combination; Fever; Health Care Costs; Humans; Neutropenia; Penicillins; Retrospective Studies | 2000 |
[Germs that produce the extended spectrum betalactamases].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors | 2004 |
Trimethoprim-sulfamethoxazole induced rash and fatal hematologic disorders.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Candidiasis, Oral; Cefepime; Cephalosporins; Chlorhexidine; Drug Eruptions; Escherichia coli; Escherichia coli Infections; Exanthema; Fatal Outcome; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Meropenem; Neutropenia; Nystatin; Platelet Transfusion; Prednisolone; Recombinant Proteins; Thienamycins; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 2006 |
[Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Combined Modality Therapy; Female; Fever; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Stem Cell Transplantation | 2006 |
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis | 2006 |
High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; Catheterization; Cefepime; Cephalosporins; Drug Resistance; Equipment Contamination; Fever; Gentamicins; Hematologic Diseases; Hematologic Neoplasms; Hospitals, Urban; Humans; Laboratories, Hospital; Medical Audit; Microbial Sensitivity Tests; Neutropenia; New Zealand; Prospective Studies; Risk Assessment; Species Specificity | 2007 |
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors | 2007 |
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2008 |
Real-time therapeutic drug monitoring of cefozopran in plasma using high-performance liquid chromatography with ultraviolet detection.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Case-Control Studies; Cefozopran; Cephalosporins; Chromatography, High Pressure Liquid; Creatinine; Drug Monitoring; Hemofiltration; Humans; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Molecular Structure; Neutropenia; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Time Factors; Ultracentrifugation | 2007 |
Pharmacodynamics of RWJ-54428 against Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecalis in a neutropenic mouse thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Enterococcus faecalis; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Mice; Microbial Sensitivity Tests; Neutropenia; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Treatment Outcome | 2008 |
[Emergence of beta-lactam-dependent Bacillus cereus associated with prolonged treatment with cefepime in a neutropenic patient].
Topics: Adolescent; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus cereus; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Female; Humans; Microbial Sensitivity Tests; Neutropenia; Risk Factors | 2007 |
Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin; Victoria | 2008 |
[In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients (author's transl)].
Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Neutropenia | 1981 |
Management of bacterial infections in haematological patients.
Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Combinations; Hematologic Diseases; Humans; Immunosuppression Therapy; Leukemia; Leukemia, Lymphoid; Lymphoma; Multiple Myeloma; Neutropenia; Penicillins; Polymyxins | 1982 |
Ceftazidime in the treatment of febrile immunosuppressed children.
Topics: Adolescent; Agranulocytosis; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neutropenia; Pilot Projects; Staphylococcal Infections; Tobramycin | 1983 |
Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Fever; Hematologic Diseases; Humans; Neutropenia; Penicillins; Prospective Studies; Ticarcillin; Tobramycin | 1983 |
Neutropenia due to beta lactamine antibodies.
Topics: Adult; Agglutination Tests; Agranulocytosis; Antibodies; Antigen-Antibody Complex; Cephalosporins; Female; Humans; Infant; Leukocytes; Male; Middle Aged; Neutropenia; Penicillins | 1983 |
Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
Topics: Agranulocytosis; Aminoglycosides; Animals; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Guinea Pigs; Netilmicin; Neutropenia; Penicillin Resistance; Penicillins; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin | 1984 |
[Semisynthetic penicillins and cephalosporins inhibit in vitro myelopoiesis in a dose-dependent manner].
Topics: Bone Marrow Cells; Cephalosporins; Depression, Chemical; Dose-Response Relationship, Drug; Hematopoiesis; Humans; Neutropenia; Penicillin G | 1983 |
Treatment and prevention of bacterial infections during cytostatic chemotherapy.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Blood Transfusion; Carbenicillin; Cephalosporins; Drug Synergism; Granulocytes; Humans; Kanamycin; Neutropenia | 1981 |
The role of schedule of antibiotic therapy on the neutropenic patient.
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Administration Schedule; Gram-Negative Aerobic Bacteria; Humans; Neutropenia | 1980 |
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins | 1995 |
Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
Topics: Bacteremia; Cephalosporins; Drug Resistance, Microbial; Humans; In Vitro Techniques; Neutropenia; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus; Vancomycin | 1994 |
Fever and neutropenia during intensive chemotherapy.
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Pseudomonas Infections; Vancomycin | 1993 |
Management of chemotherapy-induced neutropenic sepsis--combination of cephalosporin and aminoglycoside.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteria; Bacterial Infections; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia | 1993 |
The choice of antibacterial drugs.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Gram-Negative Bacteria; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Neutropenia; Penicillins; Pneumonia, Mycoplasma; Pneumonia, Staphylococcal; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1996 |
Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Cefsulodin; Cephalosporins; Combined Modality Therapy; Female; Flow Cytometry; Humans; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Neutropenia; Neutrophils; Phagocytosis; Pseudomonas Infections; Pyelonephritis | 1996 |
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.
Topics: Adolescent; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Leukocyte Count; Male; Neoplasms; Neutropenia; Neutrophils; Platelet Count; Treatment Outcome | 1996 |
Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.
Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Carboxymethylcellulose Sodium; Cephaloridine; Cephalosporins; Child; Child, Preschool; Colistin; Drug Therapy, Combination; Food Handling; Gram-Negative Bacterial Infections; Humans; Infant; Intestines; Leukemia, Myeloid, Acute; Neomycin; Neutropenia; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Sterilization; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
[Granulocyte colony-stimulating factor in the treatment of neutropenia associated with HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Anti-Infective Agents; Antiviral Agents; Ceftazidime; Cephalosporins; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Pyrimethamine; Sulfadiazine; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
[Practical use of cefepime in an University hospital. Retrospective study of 35 cases].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Glycopeptides; Hospitals, University; Humans; Injections, Intravenous; Lung Diseases; Male; Middle Aged; Neutropenia; Retrospective Studies; Sepsis | 1996 |
Pseudomonas bacteremia precipitated by ticlopidine-induced neutropenia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Filgrastim; Gentamicins; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Platelet Aggregation Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Ticlopidine | 1996 |
Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans.
Topics: Alkylating Agents; Animals; Candida albicans; Candidiasis; Ceftriaxone; Cephalosporins; Cyclophosphamide; Digestive System; Feces; Male; Mice; Mice, Inbred ICR; Neutropenia | 1996 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Ciprofloxacin; Drug Hypersensitivity; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Gentamicins; Humans; Immunocompromised Host; Metronidazole; Neutropenia; Pancreatic Pseudocyst; Penicillins; Risk Factors; Teicoplanin; Vancomycin | 1997 |
[Role of ceftriaxone in febrile neutropenia].
Topics: Ceftriaxone; Cephalosporins; Fever; Humans; Infections; Neutropenia; Risk Factors; Time Factors | 1997 |
Two cases of possible cefepime-induced neutropenia.
Topics: Adult; Cefepime; Cephalosporins; Female; Humans; Male; Neutropenia; Osteomyelitis; Wound Infection | 1997 |
Predictive value of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ceftazidime; Cephalosporins; Diarrhea; Disease Models, Animal; Female; Guinea Pigs; Imipenem; Meropenem; Movement Disorders; Neutropenia; Predictive Value of Tests; Pseudomonas Infections; Regression Analysis; Respiration; Thienamycins; Time Factors; Tobramycin; Weight Loss | 1997 |
The choice of antibacterial drugs.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Costs and Cost Analysis; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Macrolides; Meningitis, Bacterial; Meningitis, Meningococcal; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Neutropenia; Pneumococcal Infections; Pneumonia, Bacterial; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1998 |
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome | 1998 |
A retrospective study of infections in neutropenic patients.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cephalosporins; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Male; Neutropenia; Retrospective Studies | 1998 |
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Catheterization, Peripheral; Cause of Death; Cephalosporins; Chemoprevention; Female; Fungemia; Humans; Itraconazole; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Risk Factors; Trichosporon | 1999 |
Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Teicoplanin; Treatment Outcome; Vancomycin | 1999 |
Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporin Resistance; Cephalosporins; Clostridium; Clostridium Infections; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Vancomycin | 1999 |
Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Treatment Outcome | 2000 |
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 2000 |
Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome | 2000 |
Control of glycopeptide-resistant enterococci in an oncology unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Glycopeptides; Humans; Infection Control; Neoplasms; Neutropenia; Oncology Service, Hospital; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2000 |
In vitro and In vivo activities of LB 10827, a new oral cephalosporin, against respiratory pathogens.
Topics: Animals; Cephalosporins; Disease Models, Animal; Female; Haemophilus influenzae; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Moraxella catarrhalis; Neutropenia; Pneumonia, Pneumococcal; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Outcome | 2000 |
Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cell Count; Cephalosporins; Ciprofloxacin; Diagnostic Imaging; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Luminescent Measurements; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscular Diseases; Neutropenia; Tetracycline | 2001 |
High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Cephalosporin Resistance; Cephalosporins; Female; Gene Frequency; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Risk Factors; Streptococcal Infections; Streptococcus | 2001 |
Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacterial Infections; Humans; Interleukin-8; Leukemia; Lymphoma; Male; Middle Aged; Netilmicin; Neutropenia; Predictive Value of Tests; Prospective Studies | 2001 |
Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
Topics: Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Animal; Disease-Free Survival; Endotoxins; Escherichia coli; Escherichia coli Vaccines; Female; Klebsiella pneumoniae; Lipopolysaccharides; Neisseria meningitidis; Neutropenia; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Sepsis; Vaccines, Conjugate | 2001 |
Pharmacokinetics of ceftazidime in febrile neutropenic patients.
Topics: Adult; Aged; Area Under Curve; Ceftazidime; Cephalosporins; Female; Fever; Glomerular Filtration Rate; Half-Life; Humans; Injections, Intravenous; Leukemia; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia | 2001 |
Case-control study of risk factors for the development of enterococcal bacteremia.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins | 2001 |
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Microbial; Fever; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Streptococcaceae | 2001 |
Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
Topics: Animals; Bacteremia; Ceftazidime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Gram-Negative Bacterial Infections; Neutropenia; Rats; Sepsis; Survival Analysis | 2001 |
Effect of serum from different patient populations on the serum bactericidal test.
Topics: Adult; Burns; Ceftazidime; Cephalosporins; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Pseudomonas aeruginosa; Serum Bactericidal Test; Uremia | 2001 |
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefepime; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Female; Fever; Hospitals, Teaching; Humans; Male; Middle Aged; Neutropenia; Oxacillin; Practice Guidelines as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2001 |
Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Fever; Humans; Neoplasms; Neutropenia; Risk Factors | 2002 |
Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia.
Topics: Adult; Antineoplastic Agents; Ceftazidime; Cephalosporins; Female; Fever; Humans; Male; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Thienamycins | 2002 |
Management of bacterial infections in severely neutropenic subjects.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalosporins; Child; Drug Therapy, Combination; Humans; Neutropenia; Penicillin Resistance; Tobramycin | 1977 |
Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.
Topics: Agranulocytosis; Animals; Cefazolin; Cephalosporins; Cephradine; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Male; Mice; Neutropenia; Neutrophils | 1979 |
[Combination effect of KW-2228 and cephem antibiotics in a systemic infection model in neutropenic mice].
Topics: Animals; Cephalosporins; Cyclophosphamide; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Neutropenia; Recombinant Proteins | 1992 |
[Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
Topics: Adult; Aged; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Tobramycin | 1992 |
Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cefepime; Cephalosporins; Drug Design; Drug Therapy, Combination; Escherichia coli; Humans; Klebsiella pneumoniae; Mice; Molecular Sequence Data; Neutropenia; Peptide Fragments; Platelet Factor 4; Protein Conformation; Pseudomonas aeruginosa; Structure-Activity Relationship | 1992 |
[Empirical treatment of febrile episodes in patients with neutropenia in bone marrow transplantation].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bone Marrow Transplantation; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Humans; Male; Neutropenia; Premedication; Retrospective Studies; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Monotherapy for empirical management of febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Costs and Cost Analysis; Fever; Humans; Imipenem; Infections; Neutropenia; Quinolones | 1990 |
[Persistence of a positive lymphocyte stimulation test in cephalosporin-induced anaphylactic shock and the following neutropenia].
Topics: Agranulocytosis; Anaphylaxis; Cephalosporins; Child, Preschool; Humans; Lymphocyte Activation; Male; Neutropenia | 1989 |
Cephapirin-induced neutropenia.
Topics: Adult; Aged; Agranulocytosis; Cephalosporins; Cephapirin; Female; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Time Factors | 1989 |
L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals.
Topics: Animals; Bacterial Infections; Ceftazidime; Cephalosporins; Diabetes Mellitus, Experimental; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Gentamicins; Half-Life; Isoindoles; Macaca mulatta; Male; Mice; Neutropenia; Pseudomonas Infections | 1989 |
Antibiotic-induced neutropenia.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cephalosporins; Humans; Neutropenia; Penicillins | 1985 |
Antibiotic-induced neutropenia.
Topics: Agranulocytosis; Cephalosporins; Humans; Neutropenia; Penicillins | 1985 |
Cephalosporin-induced immune cytopenia in the dog: demonstration of erythrocyte-, neutrophil-, and platelet-associated IgG following treatment with cefazedone.
Topics: Anemia, Hemolytic; Animals; Antibodies; Blood Cells; Blood Platelets; Cephalosporins; Dogs; Erythrocytes; Hematologic Diseases; Immune System Diseases; Immunoglobulin G; Neutropenia; Neutrophils; Phagocytosis; Thrombocytopenia | 1988 |
The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man.
Topics: Anemia; Animals; Cefamandole; Cefazolin; Cefonicid; Cephalosporins; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Hematologic Diseases; Male; Neutropenia; Thrombocytopenia | 1987 |
Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
Topics: Agranulocytosis; Animals; Cephalosporins; Ciprofloxacin; Cyclophosphamide; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections | 1987 |
Hypersensitivity to penicillins and cephalosporins in neutropenic patients with fever.
Topics: Adult; Agranulocytosis; Bacterial Infections; Cephalosporins; Drug Hypersensitivity; Fever; Humans; Male; Neutropenia; Penicillins | 1987 |
Therapeutic efficacy of cefpiramide and cefoperazone alone and in combination with gentamicin against pseudomonal infections in neutropenic mice.
Topics: Animals; Cefoperazone; Cephalosporins; Cyclophosphamide; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Female; Gentamicins; Half-Life; Injections, Intraperitoneal; Injections, Subcutaneous; Kinetics; Lethal Dose 50; Mice; Neutropenia; Pseudomonas Infections | 1986 |
Therapy of choice for the empiric treatment of the febrile neutropenic patient.
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Neutropenia | 1986 |
Cephalosporin-induced immune neutropenia.
Topics: Adult; Agranulocytosis; Antibodies; Cefotaxime; Cefuroxime; Cephalosporins; Female; Fluorescent Antibody Technique; Granulocytes; Humans; Leukocyte Count; Neutropenia | 1985 |
Cephalosporin-induced neutropenia.
Topics: Agranulocytosis; Cephalosporins; Humans; Neutropenia | 1986 |
Cephradine-associated immune neutropenia.
Topics: Adult; Agranulocytosis; Cephalosporins; Cephradine; Drug Hypersensitivity; Female; Humans; Neutropenia | 1985 |
Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Cephalosporins; Granulocytes; Hematopoiesis; Humans; Neutropenia; Penicillins; Time Factors | 1985 |
Infection in immunocompromised patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Immunity; Immunologic Deficiency Syndromes; Infections; Neutropenia; Pneumonia | 1985 |
Use of aminoglycosides in immunocompromised patients.
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Immune Tolerance; Infusions, Parenteral; Kidney Diseases; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Sepsis | 1985 |
Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
Topics: Agranulocytosis; Anti-Bacterial Agents; Body Weight; Cephalosporins; Costs and Cost Analysis; Drug Compounding; Drug Therapy, Combination; Fever; Humans; Kentucky; Neutropenia; Pharmacy Service, Hospital; Time and Motion Studies | 1985 |
Neutropenia associated with cephapirin therapy.
Topics: Agranulocytosis; Blood Cell Count; Cephalosporins; Cephapirin; Humans; Male; Middle Aged; Neutropenia | 1972 |